李鸿杰, 唐方明. 对比剂致急性肾损伤研究进展[J]. 心脏杂志, 2015, 27(2): 241-245. DOI: 10.13191/j.chj.2015.0069
    引用本文: 李鸿杰, 唐方明. 对比剂致急性肾损伤研究进展[J]. 心脏杂志, 2015, 27(2): 241-245. DOI: 10.13191/j.chj.2015.0069
    LI Hong-jie, TANG Fang-ming. Research progress in contrast-induced acute kidney injury[J]. Chinese Heart Journal, 2015, 27(2): 241-245. DOI: 10.13191/j.chj.2015.0069
    Citation: LI Hong-jie, TANG Fang-ming. Research progress in contrast-induced acute kidney injury[J]. Chinese Heart Journal, 2015, 27(2): 241-245. DOI: 10.13191/j.chj.2015.0069

    对比剂致急性肾损伤研究进展

    Research progress in contrast-induced acute kidney injury

    • 摘要: 随着冠状动脉介入治疗的快速发展,对比剂的使用越来越广泛,但随之出现的对比剂致急性肾损伤(CI-AKI)目前已成为医院内获得性急性肾衰竭的第3位原因,并且发病率和病死率逐年增加。虽然临床研究者对CI-AKI的发病机制及危险因素研究日趋加深,但由于目前仍缺乏切实有效的防治策略,CI-AKI仍然是重要的临床问题。本文将就CI-AKI的诊断标准、发病机制、危险因素、预防策略及近期研究进展做一综述。

       

      Abstract: With the rapid development of coronary artery interventional therapy,contrast media is used more and more widely,but contrast-induced acute kidney injury( CI-AKI) ranks as the third reason for hospital-acquired acute renal failure with a yearly increase in the incidence and mortality rate. Although more studies have been conducted on the pathogenesis and clinical risk of acute renal injury induced by the contrast factors,CI-AKI is still an important clinical problem due to lack of an effective strategy for the prevention of CI-AKI. This article will focus on the recent research progress in the diagnosis,pathogenesis,risk factors,and prevention strategies of CI-AKI.

       

    /

    返回文章
    返回